ESR1 and breast carcinoma: Besides, HDAC6 is highly expressed in estrogen receptor-positive breast cancer cells and accelerates the metastatic process of breast cancer by reducing the acetylation modification of α-tubulin, enhancing microtubule activity, and promoting cell adhesion and migration (9, 11).